Literature DB >> 15996455

Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea.

Robert Steffen1, Francesco Castelli, Hans Dieter Nothdurft, Lars Rombo, N Jane Zuckerman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15996455     DOI： 10.2310/7060.2005.12207

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  31 in total

1.  A combination vaccine consisting of three live attenuated enterotoxigenic Escherichia coli strains expressing a range of colonization factors and heat-labile toxin subunit B is well tolerated and immunogenic in a placebo-controlled double-blind phase I trial in healthy adults.

Authors:  Clayton Harro; David Sack; A Louis Bourgeois; R Walker; Barbara DeNearing; Andrea Feller; Subhra Chakraborty; Charlotte Buchwaldt; Michael J Darsley
Journal:  Clin Vaccine Immunol       Date:  2011-10-12

Review 2.  Travellers' diarrhoea - pros and cons of different prophylactic measures.

Authors:  Angelika Wagner; Ursula Wiedermann
Journal:  Wien Klin Wochenschr       Date:  2009-10       Impact factor: 1.704

3.  Colonization Factors in Enterotoxigenic Escherichia coli Strains in Travelers to Mexico, Guatemala, and India Compared with Children in Houston, Texas.

Authors:  Vineetkumar B Kharat; Makhdum Ahmed; Zhi-Dong Jiang; Mark S Riddle; Herbert L DuPont
Journal:  Am J Trop Med Hyg       Date:  2016-11-14       Impact factor: 2.345

4.  Bile acids improve the antimicrobial effect of rifaximin.

Authors:  Charles Darkoh; Lenard M Lichtenberger; Nadim Ajami; Elizabeth J Dial; Zhi-Dong Jiang; Herbert L DuPont
Journal:  Antimicrob Agents Chemother       Date:  2010-06-14       Impact factor: 5.191

5.  Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine.

Authors:  Daisuke Tokuhara; Yoshikazu Yuki; Tomonori Nochi; Toshio Kodama; Mio Mejima; Shiho Kurokawa; Yuko Takahashi; Masanobu Nanno; Ushio Nakanishi; Fumio Takaiwa; Takeshi Honda; Hiroshi Kiyono
Journal:  Proc Natl Acad Sci U S A       Date:  2010-04-26       Impact factor: 11.205

Review 6.  Infection strategies of enteric pathogenic Escherichia coli.

Authors:  Abigail Clements; Joanna C Young; Nicholas Constantinou; Gad Frankel
Journal:  Gut Microbes       Date:  2012-03-01

7.  The oral, live attenuated enterotoxigenic Escherichia coli vaccine ACE527 reduces the incidence and severity of diarrhea in a human challenge model of diarrheal disease.

Authors:  Michael J Darsley; Subhra Chakraborty; Barbara DeNearing; David A Sack; Andrea Feller; Charlotte Buchwaldt; A Louis Bourgeois; Richard Walker; Clayton D Harro
Journal:  Clin Vaccine Immunol       Date:  2012-10-03

Review 8.  Rifaximin: a review of its use in the management of traveller's diarrhoea.

Authors:  Gayle W Robins; Keri Wellington
Journal:  Drugs       Date:  2005       Impact factor: 9.546

9.  Crystal structure of the full-length ATPase GspE from the Vibrio vulnificus type II secretion system in complex with the cytoplasmic domain of GspL.

Authors:  Connie Lu; Konstantin V Korotkov; Wim G J Hol
Journal:  J Struct Biol       Date:  2014-08-01       Impact factor: 2.867

10.  Binding of CFA/I Pili of Enterotoxigenic Escherichia coli to Asialo-GM1 Is Mediated by the Minor Pilin CfaE.

Authors:  T P Vipin Madhavan; James D Riches; Martin J Scanlon; Glen C Ulett; Harry Sakellaris
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.